Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2

Neurology·MeSH: Neuronal Ceroid-Lipofuscinoses

Prevalence

5.0 / 100K

1 drug in development·1 company·1 clinical trial

Drug Pipeline by Phase

Frequently asked questions

How many drugs are in development for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2?

BioSniper tracks 1 drug in development for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 across 1 company.

How many clinical trials target Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2?

There are 1 clinical trial targeting Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 tracked by BioSniper.

What is the prevalence of Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2?

The estimated prevalence of Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 is approximately 5.0 per 100,000 population.

Deep-dive into Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 — Drugs in Development & Clinical Trials | BioSniper